These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 12917408

  • 21. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
    Zhu Z, Lu D, Kotanides H, Santiago A, Jimenez X, Simcox T, Hicklin DJ, Bohlen P, Witte L.
    Cancer Lett; 1999 Mar 01; 136(2):203-13. PubMed ID: 10355750
    [Abstract] [Full Text] [Related]

  • 22. [Selection and characterization of human antibodies against vascular endothelial growth factor from human phage display antibody library].
    Tian X, Shou C, Dong Z.
    Zhonghua Yi Xue Za Zhi; 2000 Aug 01; 80(8):567-70. PubMed ID: 11798817
    [Abstract] [Full Text] [Related]

  • 23. Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope disturbing strategy.
    Lamdan H, Ayala M, Rojas G, Munoz Y, Morera Y, Guirola O, Chinea G, Gavilondo JV.
    J Biotechnol; 2011 Jan 20; 151(2):166-74. PubMed ID: 21167224
    [Abstract] [Full Text] [Related]

  • 24. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.
    Li H, Cao W, Chen Z, Acheampong DO, Jin H, Li D, Zhang J, Wang M.
    Biomed Pharmacother; 2013 Sep 20; 67(7):599-606. PubMed ID: 23906761
    [Abstract] [Full Text] [Related]

  • 25. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
    Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R.
    J Biol Chem; 2005 Jul 29; 280(30):27935-48. PubMed ID: 15923192
    [Abstract] [Full Text] [Related]

  • 26. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.
    Liang WC, Wu X, Peale FV, Lee CV, Meng YG, Gutierrez J, Fu L, Malik AK, Gerber HP, Ferrara N, Fuh G.
    J Biol Chem; 2006 Jan 13; 281(2):951-61. PubMed ID: 16278208
    [Abstract] [Full Text] [Related]

  • 27. [Effect of monoclonal antibody against extracellular domain III of vascular endothelial growth factor receptor KDR on proliferation of vascular endothelial cells].
    Li R, Xiong DS, Shao XF, Xu YF, Zhu ZP, Yang CZ.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr 13; 27(4):209-12. PubMed ID: 15949417
    [Abstract] [Full Text] [Related]

  • 28. VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.
    Herzog B, Pellet-Many C, Britton G, Hartzoulakis B, Zachary IC.
    Mol Biol Cell; 2011 Aug 01; 22(15):2766-76. PubMed ID: 21653826
    [Abstract] [Full Text] [Related]

  • 29. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.
    J Mol Biol; 1999 Nov 05; 293(4):865-81. PubMed ID: 10543973
    [Abstract] [Full Text] [Related]

  • 30. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H, Rajabibazl M, Ebrahimizadeh W, Dehbidi GR.
    Microvasc Res; 2015 Jan 05; 97():13-8. PubMed ID: 25250517
    [Abstract] [Full Text] [Related]

  • 31. Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2.
    Lu D, Kotanides H, Jimenez X, Zhou Q, Persaud K, Bohlen P, Witte L, Zhu Z.
    J Immunol Methods; 1999 Nov 19; 230(1-2):159-71. PubMed ID: 10594363
    [Abstract] [Full Text] [Related]

  • 32. Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2.
    Miao HQ, Hu K, Jimenez X, Navarro E, Zhang H, Lu D, Ludwig DL, Balderes P, Zhu Z.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):438-45. PubMed ID: 16682007
    [Abstract] [Full Text] [Related]

  • 33. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
    Shen J, Vil MD, Jimenez X, Iacolina M, Zhang H, Zhu Z.
    J Biol Chem; 2006 Apr 21; 281(16):10706-14. PubMed ID: 16481314
    [Abstract] [Full Text] [Related]

  • 34. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
    Fujisawa D, Yamazaki Y, Lomonte B, Morita T.
    Biochem J; 2008 May 01; 411(3):515-22. PubMed ID: 18251716
    [Abstract] [Full Text] [Related]

  • 35. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
    Rouet R, Dudgeon K, Christie M, Langley D, Christ D.
    J Biol Chem; 2015 May 08; 290(19):11905-17. PubMed ID: 25737448
    [Abstract] [Full Text] [Related]

  • 36. Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2.
    Yamazaki Y, Matsunaga Y, Nakano Y, Morita T.
    J Biol Chem; 2005 Aug 26; 280(34):29989-92. PubMed ID: 16014630
    [Abstract] [Full Text] [Related]

  • 37. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 38. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T, Tesar M, Griesel C, Rohde M, Gröne HJ, Waltenberger J, Kollet O, Lapidot T, Yayon A, Weich H.
    Stem Cells; 2001 Apr 01; 19(1):24-36. PubMed ID: 11209088
    [Abstract] [Full Text] [Related]

  • 39. Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
    Itokawa T, Nokihara H, Nishioka Y, Sone S, Iwamoto Y, Yamada Y, Cherrington J, McMahon G, Shibuya M, Kuwano M, Ono M.
    Mol Cancer Ther; 2002 Mar 01; 1(5):295-302. PubMed ID: 12489845
    [Abstract] [Full Text] [Related]

  • 40. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, Park IC, Rhee CH, Hong SI.
    Int J Cancer; 2006 Jun 01; 118(11):2711-20. PubMed ID: 16388516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.